The upregulation of Cyp4a14 has been proved to be involved in the PPAR signaling pathway and is related to fatty acid oxidative stress and lipid peroxidation, resulting in nonalcoholic fatty liver disease, which is one of the most common chronic liver diseases in the world [56,57]. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.